Gazzin, A.; Fornari, F.; Cardaropoli, S.; Carli, D.; Tartaglia, M.; Ferrero, G.B.; Mussa, A.
Exploring New Drug Repurposing Opportunities for MEK Inhibitors in RASopathies: A Comprehensive Review of Safety, Efficacy, and Future Perspectives of Trametinib and Selumetinib. Life 2024, 14, 731.
https://doi.org/10.3390/life14060731
AMA Style
Gazzin A, Fornari F, Cardaropoli S, Carli D, Tartaglia M, Ferrero GB, Mussa A.
Exploring New Drug Repurposing Opportunities for MEK Inhibitors in RASopathies: A Comprehensive Review of Safety, Efficacy, and Future Perspectives of Trametinib and Selumetinib. Life. 2024; 14(6):731.
https://doi.org/10.3390/life14060731
Chicago/Turabian Style
Gazzin, Andrea, Federico Fornari, Simona Cardaropoli, Diana Carli, Marco Tartaglia, Giovanni Battista Ferrero, and Alessandro Mussa.
2024. "Exploring New Drug Repurposing Opportunities for MEK Inhibitors in RASopathies: A Comprehensive Review of Safety, Efficacy, and Future Perspectives of Trametinib and Selumetinib" Life 14, no. 6: 731.
https://doi.org/10.3390/life14060731
APA Style
Gazzin, A., Fornari, F., Cardaropoli, S., Carli, D., Tartaglia, M., Ferrero, G. B., & Mussa, A.
(2024). Exploring New Drug Repurposing Opportunities for MEK Inhibitors in RASopathies: A Comprehensive Review of Safety, Efficacy, and Future Perspectives of Trametinib and Selumetinib. Life, 14(6), 731.
https://doi.org/10.3390/life14060731